Vioxx News

California Vioxx Trial Hears More Testimony About Clinical Studies

At a glance:

Jurors for the California Vioxx trial continued to view videotaped depositions on the third day of the trial. A Merck researcher, Dr. Deborah Shapiro, testified that a 1999 study of 8000 patients showed that those given Vioxx had four times the number of heart attacks than those given Aleve (naproxen), an older NSAID. 
 
Merck claims that there is no proof that Vioxx caused the plaintiff's heart attack. 
 


Merck Scientist Testifies Vioxx Caused More Heart Attacks Than ...

North County Times - 6/30/2006 3:12 PM

LOS ANGELES - People who took part in a clinical trial of the pain reliever Vioxx had heart attacks at a rate four times higher than those taking an older painkiller, a health data analyst for Merck and Co. testified today.
 
Deborah Shapiro, director of clinical biostatistics for Merck and Co. -- which marketed Vioxx from 1999 to 2004 -- said in a videotaped deposition shown to a jury that half of the 8,000 patients in the study took Vioxx and the other half naproxen, known by the brand name Aleve

 
· Read The Full Vioxx Article From North County Times -->

· Read All Vioxx (Rofecoxib) News Stories -->

Comments On Vioxx News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: